Skip to content
healthcare.dev

Ultra Bismuth

NDC 55910-637, Bismuth subsalicylate, liquid, from Dolgencorp, Inc. (DOLLAR GENERAL & REXALL).

Product NDC
55910-637
Status
Listed
Labeler
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M008
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-637 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISMUTH SUBSALICYLATE525 mg/15mL

Pharmacologic classes

Bismuth [CS]; Bismuth [EPC]

Package NDCNDC-11Package
55910-637-0455910063704118 mL in 1 BOTTLE, PLASTIC (55910-637-04)
55910-637-1255910063712355 mL in 1 BOTTLE, PLASTIC (55910-637-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-637 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-637 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-637. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.